Related Experiment Video
Updated: May 23, 2026

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
Chemerin as a mediator between obesity and vascular inflammation in children
Kathrin Landgraf1, Daniela Friebe, Tina Ullrich
1Pediatric Research Center, Department of Women's and Child Health, University of Leipzig, Liebigstrasse 20a, 04103 Leipzig, Germany.
Insights
Chemerin levels are higher in obese children and linked to inflammation and early vascular changes. This suggests chemerin may connect excess fat to an increased risk of atherosclerosis in children.
Area of Science:
- Pediatric Endocrinology
- Cardiovascular Research
- Metabolic Syndrome
Background:
- Chemerin, a chemoattractant protein, is expressed in adipose tissue.
- Obesity is associated with metabolic and vascular complications in children.
Purpose of the Study:
- To investigate the association between chemerin and obesity in children.
- To evaluate chemerin's link to early metabolic and vascular issues in pediatric obesity.
Main Methods:
- Serum chemerin levels were measured in lean and obese children.
- Associations with metabolic, inflammatory, and endothelial markers were assessed.
- In vitro studies examined chemerin's effect on endothelial cells.
Main Results:
- Obese children had significantly higher chemerin levels than lean children.
- Chemerin correlated with obesity indicators, inflammation markers (hs-CRP, WBC), and endothelial activation markers (ICAM-1, E-selectin).
- Chemerin was a strong predictor of ICAM-1 and E-selectin, and induced their expression in vitro.
Conclusions:
- Chemerin is associated with obesity, inflammation, and endothelial activation in children.
- Chemerin may serve as a link between increased fat mass and early atherogenic risk in obese children.
Context:
The chemoattractant protein chemerin has recently been shown to be expressed in adipose tissue.
Objective:
We aimed to evaluate the association of chemerin with obesity and early-onset metabolic and vascular sequelae in children.
Design:
We quantified chemerin serum levels in 69 lean and 105 obese children and assessed associations with metabolic and cardiovascular parameters. In addition, a potential direct effect of chemerin on the expression of endothelial adhesion molecules and cell viability was assessed in human coronary artery endothelial cells in vitro.
Results:
Chemerin concentrations were significantly higher in obese compared to lean children and correlated with obesity-related parameters such as body mass index sd score, leptin, and skinfold thickness. Moreover, we identified significant associations with the measures of inflammation high-sensitivity C-reactive protein and white blood cell count, as well as with the markers of endothelial activation intercellular adhesion molecule-1 (ICAM-1) and E-selectin. Multiple regression analyses confirmed chemerin as the strongest predictor of ICAM-1 and E-selectin independent of body mass index sd score. Likewise, on the cellular level, chemerin induced ICAM-1 and E-selectin expression in endothelial cells in vitro, whereas VCAM-1 and eNOS expression and endothelial cell viability were unaffected.
Conclusion:
Our results suggest an association of chemerin with obesity and inflammatory and endothelial activation markers and support a role for chemerin as a molecular link between increasing fat mass and an early atherogenic risk profile in obese children.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Obesity
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Psychoneuroimmunology: Diabetes and Cancer

